Video

Daniel J. Klein Recaps the PAN Foundation Cost-Sharing Roundtable

At the PAN Foundation Cost-Sharing Roundtable, a variety of voices were represented from across healthcare to discuss the importance of the safety net, explained Daniel J. Klein, president and CEO of the Patient Access Network (PAN) Foundation.

At the PAN Foundation Cost-Sharing Roundtable, a variety of voices were represented from across healthcare to discuss the importance of the safety net, explained Daniel J. Klein, president and CEO of the Patient Access Network (PAN) Foundation.

Transcript

What was a key takeaway from the discussions at the PAN Foundation Cost-Sharing Roundtable?

The roundtable was really pretty energizing, because I think we saw a lot of different perspectives being represented from the payer community, from the pharma community, from the patient advocacy community, from the patient assistance community. And I think my takeaway was that there are some opportunities for common understanding and broadly supported strategies.

I think everybody recognizes that paying for value-based care will free up critical dollars to be used more efficiently to provide patient assistance and I think everybody also came away understanding that the need for a safety net is probably growing. As the patients age, as we go from 57 million patients in Medicare to 70 million plus, it's likely that there's going to be a continuing need for patient assistance, for safety net programs. So it's key that we all work together across our different areas of expertise to make that as efficient as possible, to make sure that it reaches the people who need it, and that everyone can get access to the care they need.

So the roundtable, hopefully, gave everybody a good boost of energy to go back to their offices, to their jobs, to their careers, to their constituents and help move us forward in terms of strenthening and sustaining the safety net.

Related Videos
Crystal S. Denlinger, MD, FACP, CEO of the National Comprehensive Cancer Network
Tiara Green, MSEd
Ryan Jacobs, MD, Atrium Health Levine Cancer Institute
Rachel Dalthorp, MD
Quint and Petris
Andrew Cournoyer
Rebecca Flynn, Peter Lio, Timothy Caulfield, and Nichole Halliburton at SPD 2024
Related Content
CH LogoCenter for Biosimilars Logo